dimethyl fumarate mylan
mylan ireland limited - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
eviplera
gilead sciences international ltd - emtricitabine, rilpivirine hydrochloride, tenofovir disoproxil fumarate - hiv-infektiot - antiviraalit systeemiseen käyttöön - eviplera on tarkoitettu kohtelu aikuiset kanssa ilman tunnettujen mutaatioiden liittyvät-nucleoside käänteiskopioijaentsyymin estäjiin (nnrti)-, yhdistelmä-tai emtricitabine, immuunikatoviruksen tyypin 1 (hiv-1) ja virus lataa ≤ 100 000 hiv-1 rna kopiota/ml. kuten muillakin antiretroviraalilääkkeillä, genotyyppisen resistenssin testauksen ja / tai historiallisten resistanssitietojen tulisi ohjata eviplera.
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
bisoprolol vitabalans 5 mg tabletti
vitabalans oy - bisoprolol hemifumarate - tabletti - 5 mg - bisoprololi
bisoprolol vitabalans 10 mg tabletti
vitabalans oy - bisoprolol hemifumarate - tabletti - 10 mg - bisoprololi
quetiapine accord 25 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - quetiapine hemifumarate - tabletti, kalvopäällysteinen - 25 mg - ketiapiini